UPDATE: Compugen Licenses Gencarta Database to Japanese Pharma Kyowa-Hakko | GenomeWeb

This article has been updated from a previous version.  

NEW YORK, July 17 – Compugen licensed its Gencarta database of annotated genomic, transcription, and proteomic data to the Japanese pharmaceutical company Kyowa-Hakko Kogyo, the companies announced Tuesday.

The license, which includes access to human, mice, and rat data, is for two years and is an all-cash agreement with payments up-front each year, said Eli Mintz, president of Compugen. The company would not disclose the license fee.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.